Thomas A. Ullman, M.D.

Medicine

Phone914-631-2895
Emailtullman@montefiore.org
Websitehttp://www.einstein.yu.edu/faculty/15701/thomas-ullman/

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Thomas A. Ullman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Finished

Preventing Neoplastic Progression in Ulcerative Colitis
Ullman, T. A.
National Institute of Diabetes and Digestive and Kidney Diseases
9/15/05 → 8/31/10
Project: Research project

5398 Citations
35 h-Index
58 Article
13 Review article
8 Editorial
7 Comment/debate
More

Stopping Mesalamine Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes
Ungaro, R. C., Limketkai, B. N., Jensen, C. B., Yzet, C., Allin, K. H., Agrawal, M., Ullman, T., Burisch, J., Jess, T. & Colombel, J. F., May 2020, In: Clinical Gastroenterology and Hepatology. 18, 5, p. 1152-1160.e1
Research output: Contribution to journal › Article › peer-review
6 Scopus citations
Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases
Papamichael, K., Cheifetz, A. S., Melmed, G. Y., Irving, P. M., Vande Casteele, N., Kozuch, P. L., Raffals, L. E., Baidoo, L., Bressler, B., Devlin, S. M., Jones, J., Kaplan, G. G., Sparrow, M. P., Velayos, F. S., Ullman, T. & Siegel, C. A., Aug 2019, In: Clinical Gastroenterology and Hepatology. 17, 9, p. 1655-1668.e3
Research output: Contribution to journal › Article › peer-review

Open Access
51 Scopus citations
Consecutive negative findings on colonoscopy during surveillance predict a low risk of advanced neoplasia in patients with inflammatory bowel disease with long-standing colitis: Results of a 15-year multicentre, multinational cohort study
Ten Hove, J. R., Shah, S. C., Shaffer, S. R., Bernstein, C. N., Castaneda, D., Palmela, C., Mooiweer, E., Elman, J., Kumar, A., Glass, J., Axelrad, J., Ullman, T. A., Colombel, J. F., Torres, J., Van Bodegraven, A. A., Hoentjen, F., Jansen, J. M., De Jong, M. E., Mahmmod, N., Van Der Meulen-De Jong, A. E. & 4 others, Ponsioen, C. Y., Van Der Woude, C. J., Itzkowitz, S. H. & Oldenburg, B., Apr 1 2019, In: Gut. 68, 4, p. 615-622 8 p.
Research output: Contribution to journal › Article › peer-review
9 Scopus citations
Gut microbiota density influences host physiology and is shaped by host and microbial factors
Contijoch, E. J., Britton, G. J., Yang, C., Mogno, I., Li, Z., Ng, R., Llewellyn, S. R., Hira, S., Johnson, C., Rabinowitz, K. M., Barkan, R., Dotan, I., Hirten, R. P., Fu, S. C., Luo, Y., Yang, N., Luong, T., Labrias, P. R., Lira, S., Peter, I. & 54 others, Grinspan, A., Clemente, J. C., Kosoy, R., Kim-Schulze, S., Qin, X., Castillo, A., Hurley, A., Atreja, A., Rogers, J., Fasihuddin, F., Saliaj, M., Nolan, A., Reyes-Mercedes, P., Rodriguez, C., Aly, S., Santa-Cruz, K., Peters, L., Suárez-Fariñas, M., Huang, R., Hao, K., Zhu, J., Zhang, B., Losic, B., Irizar, H., Song, W. M., Di Narzo, A., Wang, W., Cohen, B. L., DiMaio, C., Greenwald, D., Itzkowitz, S., Lucas, A., Marion, J., Maser, E., Ungaro, R., Naymagon, S., Novak, J., Shah, B., Ullman, T., Rubin, P., George, J., Legnani, P., Telesco, S. E., Friedman, J. R., Brodmerkel, C., Plevy, S., Cho, J. H., Colombel, J. F., Schadt, E. E., Argmann, C., Dubinsky, M., Kasarskis, A., Sands, B. & Faith, J. J., Jan 22 2019, In: eLife. 8, e40553.
Research output: Contribution to journal › Article › peer-review

Open Access
37 Scopus citations
No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases
Dutch Initiative on Crohn and Colitis, Apr 2019, In: Gastroenterology. 156, 5, p. 1333-1344.e3
Research output: Contribution to journal › Article › peer-review
10 Scopus citations

Preventing Neoplastic Progression in Ulcerative Colitis

Stopping Mesalamine Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

Consecutive negative findings on colonoscopy during surveillance predict a low risk of advanced neoplasia in patients with inflammatory bowel disease with long-standing colitis: Results of a 15-year multicentre, multinational cohort study

Gut microbiota density influences host physiology and is shaped by host and microbial factors

No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases